Merck Revenue 2012-2026 | MRK

Merck revenue for the twelve months ending March 31, 2026 was $65.768B, a 2.89% increase year-over-year.

  • Merck annual revenue for 2025 was $65.011B, a 1.31% increase from 2024.
  • Merck annual revenue for 2024 was $64.168B, a 6.74% increase from 2023.
  • Merck annual revenue for 2023 was $60.115B, a 1.4% increase from 2022.

Merck Revenue 2012-2026 | MRK

  • Merck annual revenue for 2025 was $65.011B, a 1.31% increase from 2024.
  • Merck annual revenue for 2024 was $64.168B, a 6.74% increase from 2023.
  • Merck annual revenue for 2023 was $60.115B, a 1.4% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B